Avivagen (VIV) News Today C$0.0050 0.00 (0.00%) (As of 03/5/2024) Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Avivagen Inc (VIV)March 6, 2024 | investing.comCanadian Investment Regulatory Organization Trading Halt - VIVMarch 6, 2024 | finance.yahoo.comAvivagen: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (VIV)February 20, 2024 | theglobeandmail.comPure Harvest Corporate Group, Inc. (PHCG)January 3, 2024 | finance.yahoo.comClosing Bell: Avivagen Inc flat on Monday (VIV)November 5, 2023 | theglobeandmail.comAvivagen Announces New 500Kg Order for OxC-beta™October 17, 2023 | finance.yahoo.comClosing Bell: Avivagen Inc flat on Friday (VIV)August 25, 2023 | theglobeandmail.comAvivagen Provides Corporate UpdatesJuly 31, 2023 | technews.tmcnet.comClosing Bell: Avivagen Inc up on Friday (VIV)July 29, 2023 | theglobeandmail.comAvivagen Announces New Orders for 1.1 Tonnes of Oxc-Beta™ Livestock ProductJuly 24, 2023 | finance.yahoo.comClosing Bell: Avivagen Inc flat on Tuesday (VIV)July 19, 2023 | theglobeandmail.comAvivagen: Top 10 Undervalued Growth Stocks on TSX-V (VIV)July 15, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc down on Monday (VIV)June 27, 2023 | theglobeandmail.comAn existing Avivagen customer increases order sizeMay 25, 2023 | msn.comAvivagen Announces Significant Increase in Sales to an Existing CustomerMay 25, 2023 | finance.yahoo.comAvivagen Inc. (VIV.V)May 23, 2023 | sg.finance.yahoo.comAvivagen Announces Review of Strategic AlternativesMay 18, 2023 | tmcnet.comClosing Bell: Avivagen Inc down on Thursday (VIV)April 27, 2023 | theglobeandmail.comAvivagen Announces AGM ResultsApril 19, 2023 | finance.yahoo.comClosing Bell: Avivagen Inc flat on Thursday (VIV)April 7, 2023 | theglobeandmail.comClosing Bell: Avivagen Inc flat on Wednesday (VIV)April 6, 2023 | theglobeandmail.comAvivagen Inc. Provides Update on Securities for Service Agreements With CEO and CSOMarch 28, 2023 | finance.yahoo.comAvivagen First Quarter 2023 Earnings: CA$0.015 loss per share (vs CA$0.027 loss in 1Q 2022)March 18, 2023 | finance.yahoo.comAvivagen reports FY resultsFebruary 21, 2023 | msn.comAvivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate GrowthFebruary 21, 2023 | finance.yahoo.comAvivagen Inc. (VIVXF) Interactive Stock Chart - Yahoo FinanceJanuary 20, 2023 | finance.yahoo.comAvivagen Inc. (VIVXF)January 13, 2023 | uk.finance.yahoo.comMerry ChristmasDecember 26, 2022 | baystreet.caAvivagen Inc. Announces Securities for Service Agreements With CEO and CSODecember 22, 2022 | yahoo.comAvivagen Inc. Announces Closing of First Tranche of a Non-Brokered Private Placement of Shares for Proceeds of up to $1.0 MillionOctober 21, 2022 | finance.yahoo.comAvivagen Inc. Announces Proposed Non-Brokered Private Placement of Common Shares for Proceeds of up to $1.0 MillionOctober 14, 2022 | finance.yahoo.comAvivagen Earnings, Revenue Miss in Q3September 17, 2022 | investing.comAvivagen reports Q3 resultsSeptember 17, 2022 | seekingalpha.comStocks in play: Avivagen IncSeptember 16, 2022 | ca.finance.yahoo.comAvivagen Announces Publication of Peer-Reviewed Article in Food and Chemical Toxicology JournalSeptember 7, 2022 | yahoo.comVIVXF: OxC-beta Approved in China…August 31, 2022 | finance.yahoo.comStocks in play: Avivagen Inc.August 19, 2022 | ca.finance.yahoo.comAvivagen Announces Receipt of Repeat Order from Asian CustomerAugust 11, 2022 | apnews.comAvivagen Announces Significant Order of OxC-beta™ in BrazilAugust 3, 2022 | apnews.comAvivagen Announces Sales of Companion Animal Product and Management ChangeJuly 29, 2022 | finance.yahoo.comAvivagen Inc. Announces Closing of Third Tranche of a Private Placement of Shares and WarrantsJuly 6, 2022 | finance.yahoo.comAvivagen Inc. Announces Options GrantJune 20, 2022 | finance.yahoo.comAvivagen Announces Successful Completion of Formal Safety and Toxicology Evaluation of Fully Oxidized Beta-Carotene (OxBC)June 9, 2022 | nz.finance.yahoo.comAvivagen gaining traction with its oxidized carotenoid-based feed additive in international marketsJune 8, 2022 | ca.proactiveinvestors.comAvivagen Provides Second Update on Non-Brokered Private PlacementJune 3, 2022 | finance.yahoo.comAvivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares and Warrants for Proceeds of Up to $5.0 MillionMay 31, 2022 | apnews.comAvivagen Announces Approval in China, the World's Largest Commercial Feed Production MarketMay 12, 2022 | stockhouse.comVIVXF: OxC-beta Approved in Vietnam…May 9, 2022 | finance.yahoo.comAvivagen Provides Update on Non-Brokered Private PlacementMay 6, 2022 | apnews.comAvivagen Inc. Announces Closing of First Tranche of a Private Placement of Shares and Warrants for Proceeds of up to $5.0 MillionApril 28, 2022 | morningstar.com Get Avivagen News Delivered to You Automatically Sign up to receive the latest news and ratings for VIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. VIV Media Mentions By Week VIV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VIV News Sentiment▼0.000.60▲Average Medical News Sentiment VIV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VIV Articles This Week▼00▲VIV Articles Average Week Get Avivagen News Delivered to You Automatically Sign up to receive the latest news and ratings for VIV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCE News Today T News Today RCI.B News Today RCI.A News Today AMX News Today CJR.B News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:VIV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avivagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avivagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIV Stock Alerts